Vir Biotechnology
208 hedge funds and large institutions have $652M invested in Vir Biotechnology in 2024 Q4 according to their latest regulatory filings, with 42 funds opening new positions, 69 increasing their positions, 69 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.35% more ownership
Funds ownership: 64.11% → 64.47% (+0.35%)
0% more repeat investments, than reductions
Existing positions increased: 69 | Existing positions reduced: 69
1% less capital invested
Capital invested by funds: $656M → $652M (-$4.23M)
Holders
208
Holding in Top 10
3
Calls
$9.81M
Puts
$4.07M
Top Buyers
| 1 | +$8.55M | |
| 2 | +$8.32M | |
| 3 | +$7.24M | |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
+$7.08M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$6.65M |
Top Sellers
| 1 | -$17.8M | |
| 2 | -$8.13M | |
| 3 | -$4.34M | |
| 4 |
D.E. Shaw & Co
New York
|
-$3.38M |
| 5 |
O
OrbiMed
New York
|
-$2.8M |